Your browser doesn't support javascript.
loading
Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis.
Yoshifuji, Ayumi; Toda, Masataro; Ryuzaki, Munekazu; Kikuchi, Kan; Kawai, Toru; Sakai, Ken; Oyama, Emi; Koinuma, Masayoshi; Katayama, Kazuhiko; Uehara, Yuki; Ohmagari, Norio; Kanno, Yoshihiko; Kon, Hirofumi; Shinoda, Toshio; Takano, Yaoko; Tanaka, Junko; Hora, Kazuhiko; Nakazawa, Yasushi; Hasegawa, Naoki; Hanafusa, Norio; Hinoshita, Fumihiko; Morikane, Keita; Wakino, Shu; Nakamoto, Hidetomo; Takemoto, Yoshiaki.
Afiliação
  • Yoshifuji A; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Toda M; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
  • Ryuzaki M; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
  • Kikuchi K; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Kawai T; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
  • Sakai K; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Oyama E; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Koinuma M; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Katayama K; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Uehara Y; Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo, Japan.
  • Ohmagari N; Laboratory of Viral Infection Control, Omura Satoshi Memorial Institute, Graduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan.
  • Kanno Y; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Kon H; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Shinoda T; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Takano Y; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Tanaka J; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Hora K; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Nakazawa Y; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Hasegawa N; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Hanafusa N; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Hinoshita F; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Morikane K; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Wakino S; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Nakamoto H; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Takemoto Y; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
Ren Replace Ther ; 8(1): 39, 2022.
Article em En | MEDLINE | ID: mdl-35999867
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Ren Replace Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Ren Replace Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão